In vivo dual-targeted chemotherapy of drug resistant cancer by rationally designed nanocarrier-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vivo dual-targeted chemotherapy of drug resistant cancer by rationally designed nanocarrier

Published:2016-01 Issue: Volume:75 Page:71-81
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Wang Yang,Zhao Ruibo,Wang Shibing,Liu Zhaoming,Tang Ruikang

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference47 articles.

1. Theranostic nanoshells: from probe design to imaging and treatment of cancer;Bardhan;Acc. Chem. Res.,2011

2. Nanocarriers as an emerging platform for cancer therapy;Peer;Nat. Nanotechnol.,2007

3. Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions;Sotaniemi;Clin. Pharmacol. Ther.,1997

4. Stimuli-responsive nanocarriers for drug delivery;Mura;Nat. Mater,2013

5. Multiple drug resistance;Mitscher;Med. Res. Rev.,1999

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on the biomedical frontiers of nanowire applications;Heliyon;2024-04

2. Therapeutic Approaches of Dual-targeted Nanomedicines for Tumor Multidrug Resistance;Current Drug Delivery;2024-02

3. H₂O₂-triggered CO release based on porphyrinic covalent organic polymers for photodynamic/gas synergistic therapy;Chemical Communications;2024

4. Regulation of magnetic moment and magnetic anisotropy of magnetite by doping transition metal elements;Acta Physica Sinica;2024

5. Advantages of Magnetic Iron Oxide Nanoparticles for Cancer Photothermal Therapy;Laser-triggered Nanobiomaterials for Inhibiting Tumor Growth;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3